EMA: parent whenever possible [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-09-20 14:53 (4660 d 16:53 ago) – Posting: # 11531
Views: 32,274

Hi CR,

❝ So, do you recommend analysing both Spironolactone and the metabolites? If so, BE criteria (for MHRA) will be based on parent or both?


If you reliably can measure spironolactone, there is no need to measure any of its metabolites.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
130 visitors (0 registered, 130 guests [including 13 identified bots]).
Forum time: 07:46 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5